IDEAS TO IND — YOUR PATHWAY TO DISCOVERY
ONE PARTNER
EVERY STAGE
20
Years of Genetic Innovation
10,700
Global Bioscience Partners
50,000
Mouse & Rat Models Delivered
16,500
SCI Journal Citations
250,000
SPF Animals in AAALAC-Accredited Facilities
Animal
Innovative Solutions & Trusted Products
Special Promotions & Discounts
See All Promotions
Your Partners in Preclinical Progress
Pioneering life science advancements to deliver real-world health solutions.
Our Solutions: Integrated preclinical services, including:
- ● Cell & animal model development and viral packaging.
- ● Expert-led preclinical studies.
Your Outcome: Seamlessly translating innovative research into actionable results and successful IND applications.
Citation Database
Molecular Therapy: Methods & Clinical Development, March, 2025
Intracranial AAV administration dose-dependently recruits B cells to inhibit the AAV redosing
【Other】
Gut, February, 2025
E-twenty-six-specific sequence variant 5 (ETV5) facilitates hepatocellular carcinoma progression and metastasis through enhancing polymorphonuclear myeloid-derived suppressor cell (PMN-MDSC)-mediated immunosuppression
【Other】
Cell Death & Disease, February, 2025
Mcm5 mutation leads to silencing of Stat1-bcl2 which accelerating apoptosis of immature T lymphocytes with DNA damage
【Other】
Molecular Therapy, February, 2025
Single-cell data-driven design of armed oncolytic virus to boost cooperative innate-adaptive immunity against cancer
【Other】
Resource Library
BLOG & INSIGHTS
More Insights
Targeted AAV Delivery Strategies for Adipose Tissue: From the Discovery of the Novel BAT Target to In Vivo Validation
Navigating the complexities of adipose tissue gene delivery. This guide explores how AAV serotypes and tissue-specific promoters enable precise metabolic research, from the SLIT3 pathway to functional validation in animal models.
April 10, 2026
Read Now
UPCOMING EVENT
More
Life Science Exhibits at Vanderbilt University
Cyagen will be attending the Life Science Exhibits at Vanderbilt University on Apr 7. Our experts will be available to discuss advanced techniques in genetically engineered mouse model generation and explore how next-generation customized animal models can support and accelerate academic research.
Schedule Meeting
WEBINAR
More
Interferons: From Basic Biology to Translational Applications
Interferons (IFNs) are pivotal cytokines orchestrating antiviral defense, immune modulation, and oncological responses. However, despite decades of clinical application, their broad therapeutic utility is frequently hindered by systemic toxicity, off-target effects, and unpredictable patient heterogeneity.This webinar introduces the fundamental biology of interferons, addressing the critical question of why there are so many interferon subtypes and exploring their unique biological significance.
Schedule Meeting
